Nantahala Capital Management LLC Acquires New Position in USANA Health Sciences, Inc. $USNA

Nantahala Capital Management LLC acquired a new position in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 810,074 shares of the company's stock, valued at approximately $17,295,080. Nantahala Capital Management LLC owned 4.39% of USANA Health Sciences at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Pzena Investment Management LLC acquired a new position in USANA Health Sciences during the second quarter worth $25,739,000. Lazard Asset Management LLC acquired a new stake in USANA Health Sciences in the 1st quarter valued at $1,265,000. UBS Group AG increased its stake in USANA Health Sciences by 252.3% in the 4th quarter. UBS Group AG now owns 138,334 shares of the company's stock valued at $2,715,000 after buying an additional 99,063 shares during the last quarter. Algert Global LLC lifted its position in USANA Health Sciences by 91.8% during the 2nd quarter. Algert Global LLC now owns 131,758 shares of the company's stock worth $2,813,000 after buying an additional 63,074 shares in the last quarter. Finally, Vident Advisory LLC bought a new stake in USANA Health Sciences during the 2nd quarter worth about $437,000. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at USANA Health Sciences

In other news, Director John Turman Fleming sold 2,450 shares of the company's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $17.93, for a total value of $43,928.50. Following the sale, the director directly owned 4,230 shares of the company's stock, valued at approximately $75,843.90. This represents a 36.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Brent Neidig sold 5,002 shares of the firm's stock in a transaction dated Tuesday, June 16th. The shares were sold at an average price of $19.45, for a total transaction of $97,288.90. Additional details regarding this sale are available in the official SEC disclosure. 0.82% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Weiss Ratings restated a "sell (d)" rating on shares of USANA Health Sciences in a report on Wednesday, June 24th. Wall Street Zen lowered USANA Health Sciences from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Finally, Zacks Research cut USANA Health Sciences from a "hold" rating to a "strong sell" rating in a research report on Thursday, August 6th. Two equities research analysts have rated the stock with a Sell rating, According to data from MarketBeat, USANA Health Sciences has an average rating of "Sell".

USANA Health Sciences Trading Down 0.3%

Shares of USNA opened at $14.06 on Friday. The company has a market cap of $259.83 million, a price-to-earnings ratio of -11.62, a PEG ratio of 1.55 and a beta of 0.73. USANA Health Sciences, Inc. has a 1-year low of $12.57 and a 1-year high of $32.29. The company's fifty day simple moving average is $18.84 and its 200 day simple moving average is $18.81.

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.50). USANA Health Sciences had a positive return on equity of 3.41% and a negative net margin of 2.43%.The firm had revenue of $223.27 million for the quarter, compared to the consensus estimate of $235.00 million. USANA Health Sciences has set its FY 2026 guidance at 0.760-0.760 EPS. As a group, research analysts forecast that USANA Health Sciences, Inc. will post 0.76 earnings per share for the current year.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company's portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA's products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source